Exact Mass: 511.2781
Exact Mass Matches: 511.2781
Found 500 metabolites which its exact mass value is equals to given mass value 511.2781
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cytochalasin Ppho
Cytochalasin Ppho is produced by Phomopsis sp Production by Phomopsis species
AFN911
AFN911 is a cytochrome P450 (CYP2D6) metabolite of Imatinib. Imatinib is a tyrosine kinase inhibitor, which is used to treat chronic myelogenous leukemia (CML) with BCR-ABL activity, gastrointestinal stromal tumors and acute lymphocytic leukemia (ALL). AFN911 is a 2-phenyl amino pyrimidine derivative. AFN911 is only found in individuals who have consumed or received the drug Imatinib.
CGP72383
CGP72383 is a metabolite of Imatinib. Cgp72383 belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2.
Cholylcysteine
(3S,3aR,4S,5R,7R,8S,10S,12S,15R,15aR)-15-(acetyloxy)-2,3,3a,4,5,7,8,9,10,11,12,15-dodecahydro-5,7,8-trihydroxy-4,5,10,12-tetramethyl-3-(phenylmethyl)-1H-cycloundec[d]isoindol-1-one|21-(acetyloxy)-6,13,14-trihydroxy-16,18-dimethyl-10-phenyl[11]cytochalasa-7,19-dien-1-one
Ser Ile His Arg
His Lys Ile Asp
His Ala Arg Glu
Ala Glu His Arg
Ala Glu Arg His
Ala Phe Phe Lys
Ala Phe Lys Phe
Ala His Glu Arg
Ala His Arg Glu
Ala His Val Trp
Ala His Trp Val
Ala Lys Phe Phe
Ala Lys Met Tyr
Ala Lys Tyr Met
Ala Met Lys Tyr
Ala Arg Glu His
Ala Arg His Glu
Ala Val His Trp
Ala Val Trp His
Ala Trp His Val
Ala Trp Val His
Asp His Ile Lys
Asp His Lys Ile
Asp His Lys Leu
Asp His Leu Lys
Asp Ile His Lys
Asp Ile Lys His
Asp Lys His Ile
Asp Lys His Leu
Asp Lys Ile His
Asp Lys Leu His
Asp Leu His Lys
Asp Leu Lys His
Glu Ala His Arg
Glu Ala Arg His
Glu His Ala Arg
Glu His Lys Val
Glu His Arg Ala
Glu His Val Lys
Glu Lys His Val
Glu Lys Val His
Glu Arg Ala His
Glu Arg His Ala
Glu Val His Lys
Glu Val Lys His
Phe Ala Phe Lys
Phe Ala Lys Phe
Phe Phe Ala Lys
Phe Phe Lys Ala
Phe Lys Ala Phe
Phe Lys Phe Ala
Gly His Ile Trp
Gly His Leu Trp
Gly His Trp Ile
Gly His Trp Leu
Gly Ile His Trp
Gly Ile Trp His
Gly Leu His Trp
Gly Leu Trp His
Gly Trp His Ile
Gly Trp His Leu
Gly Trp Ile His
Gly Trp Leu His
His Ala Glu Arg
His Ala Val Trp
His Ala Trp Val
His Asp Ile Lys
His Asp Lys Ile
His Asp Lys Leu
His Asp Leu Lys
His Glu Ala Arg
His Glu Lys Val
His Glu Arg Ala
His Glu Val Lys
His Gly Ile Trp
His Gly Leu Trp
His Gly Trp Ile
His Gly Trp Leu
His Ile Asp Lys
His Ile Gly Trp
His Ile Lys Asp
His Ile Arg Ser
His Ile Ser Arg
His Ile Trp Gly
His Lys Asp Ile
His Lys Asp Leu
His Lys Glu Val
His Lys Leu Asp
His Lys Met Pro
His Lys Asn Asn
His Lys Pro Met
His Lys Val Glu
His Leu Asp Lys
His Leu Gly Trp
His Leu Lys Asp
His Leu Arg Ser
His Leu Ser Arg
His Leu Trp Gly
His Met Lys Pro
His Met Pro Lys
His Asn Lys Asn
His Asn Asn Lys
His Pro Lys Met
His Pro Met Lys
His Arg Ala Glu
His Arg Glu Ala
His Arg Ile Ser
His Arg Leu Ser
His Arg Ser Ile
His Arg Ser Leu
His Arg Thr Val
His Arg Val Thr
His Ser Ile Arg
His Ser Leu Arg
His Ser Arg Ile
His Ser Arg Leu
His Thr Arg Val
His Thr Val Arg
His Val Ala Trp
His Val Glu Lys
His Val Lys Glu
His Val Arg Thr
His Val Thr Arg
His Val Trp Ala
His Trp Ala Val
His Trp Gly Ile
His Trp Gly Leu
His Trp Ile Gly
His Trp Leu Gly
His Trp Val Ala
Ile Asp His Lys
Ile Asp Lys His
Ile Gly His Trp
Ile Gly Trp His
Ile His Asp Lys
Ile His Gly Trp
Ile His Lys Asp
Ile His Arg Ser
Ile His Ser Arg
Ile His Trp Gly
Ile Lys Asp His
Ile Lys His Asp
Ile Pro Pro Trp
Ile Pro Trp Pro
Ile Arg His Ser
Ile Arg Ser His
Ile Ser His Arg
Ile Ser Arg His
Ile Trp Gly His
Ile Trp His Gly
Ile Trp Pro Pro
Lys Ala Phe Phe
Lys Asp His Ile
Lys Asp His Leu
Lys Asp Ile His
Lys Asp Leu His
Lys Glu His Val
Lys Glu Val His
Lys Phe Ala Phe
Lys Phe Phe Ala
Lys His Asp Ile
Lys His Asp Leu
Lys His Glu Val
Lys His Ile Asp
Lys His Leu Asp
Lys His Met Pro
Lys His Asn Asn
Lys His Pro Met
Lys His Val Glu
Lys Ile Asp His
Lys Ile His Asp
Lys Leu Asp His
Lys Leu His Asp
Lys Met His Pro
Lys Met Pro His
Lys Asn His Asn
Lys Asn Asn His
Lys Pro His Met
Lys Pro Met His
Lys Thr Thr Tyr
Lys Thr Tyr Thr
Lys Val Glu His
Lys Val His Glu
Lys Tyr Thr Thr
Leu Asp His Lys
Leu Asp Lys His
Leu Gly His Trp
Leu Gly Trp His
Leu His Asp Lys
Leu His Gly Trp
Leu His Lys Asp
Leu His Arg Ser
Leu His Ser Arg
Leu His Trp Gly
Leu Lys Asp His
Leu Lys His Asp
Leu Pro Pro Trp
Leu Pro Trp Pro
Leu Arg His Ser
Leu Arg Ser His
Leu Ser His Arg
Leu Ser Arg His
Leu Trp Gly His
Leu Trp His Gly
Leu Trp Pro Pro
Met His Lys Pro
Met His Pro Lys
Met Lys His Pro
Met Lys Pro His
Met Pro His Lys
Met Pro Lys His
Asn His Lys Asn
Asn His Asn Lys
Asn Lys His Asn
Asn Lys Asn His
Asn Asn His Lys
Asn Asn Lys His
Pro His Lys Met
Pro His Met Lys
Pro Ile Pro Trp
Pro Ile Trp Pro
Pro Lys His Met
Pro Lys Met His
Pro Leu Pro Trp
Pro Leu Trp Pro
Pro Met His Lys
Pro Met Lys His
Pro Pro Ile Trp
Pro Pro Leu Trp
Pro Pro Trp Ile
Pro Pro Trp Leu
Pro Trp Ile Pro
Pro Trp Leu Pro
Pro Trp Pro Ile
Pro Trp Pro Leu
Arg Ala Glu His
Arg Ala His Glu
Arg Glu Ala His
Arg Glu His Ala
Arg His Ala Glu
Arg His Glu Ala
Arg His Ile Ser
Arg His Leu Ser
Arg His Ser Ile
Arg His Ser Leu
Arg His Thr Val
Arg His Val Thr
Arg Ile His Ser
Arg Ile Ser His
Arg Leu His Ser
Arg Leu Ser His
Arg Ser His Ile
Arg Ser His Leu
Arg Ser Ile His
Arg Ser Leu His
Arg Thr His Val
Arg Thr Val His
Arg Val His Thr
Arg Val Thr His
Ser His Ile Arg
Ser His Leu Arg
Ser His Arg Ile
Ser His Arg Leu
Ser Ile Arg His
Ser Leu His Arg
Ser Leu Arg His
Ser Arg His Ile
Ser Arg His Leu
Ser Arg Ile His
Ser Arg Leu His
Thr His Arg Val
Thr His Val Arg
Thr Lys Thr Tyr
Thr Lys Tyr Thr
Thr Arg His Val
Thr Arg Val His
Thr Thr Lys Tyr
Thr Thr Tyr Lys
Thr Val His Arg
Thr Val Arg His
Thr Tyr Lys Thr
Thr Tyr Thr Lys
Val Ala His Trp
Val Ala Trp His
Val Glu His Lys
Val Glu Lys His
Val His Ala Trp
Val His Glu Lys
Val His Lys Glu
Val His Arg Thr
Val His Thr Arg
Val His Trp Ala
Val Lys Glu His
Val Lys His Glu
Val Arg His Thr
Val Arg Thr His
Val Thr His Arg
Val Thr Arg His
Val Trp Ala His
Val Trp His Ala
Trp Ala His Val
Trp Ala Val His
Trp Gly His Ile
Trp Gly His Leu
Trp Gly Ile His
Trp Gly Leu His
Trp His Ala Val
Trp His Gly Ile
Trp His Gly Leu
Trp His Ile Gly
Trp His Leu Gly
Trp His Val Ala
Trp Ile Gly His
Trp Ile His Gly
Trp Ile Pro Pro
Trp Leu Gly His
Trp Leu His Gly
Trp Leu Pro Pro
Trp Pro Ile Pro
Trp Pro Leu Pro
Trp Pro Pro Ile
Trp Pro Pro Leu
Trp Val Ala His
Trp Val His Ala
Tyr Lys Thr Thr
Tyr Thr Lys Thr
Tyr Thr Thr Lys
AFN911
Cytochalasin Ppho
Hydrocortamate Hydrochloride
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
1,1-(Isopropylimino)bis{3-[4-(2-methoxyethyl)phenoxy]-2-propanol} hydrochloride (1:1)
BUTANE
CGP72383 is a metabolite of Imatinib. Cgp72383 belongs to the family of Acyclic Alkanes. These are acyclic hydrocarbons consisting only of n carbon atoms and m hydrogen atoms where m=2*n + 2. Aerosol propellant
1-Octadecanoyl-sn-glycero-3-phospho-(1-sn-glycerol)(1-)
[(2S,3S,5S)-2-[(3S,5S,8S,9S,10R,13S,14S,17R)-3-hydroxy-10,13-dimethyl-6-oxo-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-5,6-dimethylheptan-3-yl] sulfate
[(2R,3S,4S,5R,6S)-4-amino-6-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,5S,6R)-3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxyoxan-2-yl]methyl carbamate
1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
N-[(5S,6R,9R)-5-methoxy-8-[(2-methoxyphenyl)methyl]-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
1-[[(2R,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(3,5-dimethyl-4-isoxazolyl)-1-methylurea
1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
N-[(3S,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3R,9R,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
N-[(3R,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3S,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3R,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
(2R)-2-[(4R,5R)-5-[[cyclopentylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[2-(3-pyridinyl)ethynyl]-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(4R,7R,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7S,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-1,3-benzodioxole-5-carboxamide
1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
N-[(3R,9S,10R)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3R,9S,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3R,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3R,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3S,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3S,9R,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3S,9R,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3S,9R,10S)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3S,9S,10S)-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
N-[(3R,9S,10R)-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-9-(methylaminomethyl)-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]benzamide
(2S)-2-[(4R,5R)-5-[[cyclopentylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-8-[2-(3-pyridinyl)ethynyl]-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-(dimethylamino)-N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(pyridin-4-yl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7R,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
N-[(4S,7S,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclopropanecarboxamide
4-methoxy-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
(3R)-2-[(R)-tert-butylsulfinyl]-4-[3-(1-cyclopentenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3S)-2-[(S)-tert-butylsulfinyl]-4-[3-(1-cyclopentenyl)phenyl]-3-(2-hydroxyethyl)-N-(2-methoxyethyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
eurysterol B(1-)
An organosulfonate oxoanion obtained by the deprotonation of the sulfate group of eurysterol B hydrogen sulfate.
11beta,17-dihydroxy-3,20-dioxopregn-4-en-21-yl N,N-diethylglycinate hydrochloride
[(2S)-2,3-dihydroxypropyl] [(2S)-2-hydroxy-3-octadecanoyloxypropyl] phosphate
2-aminoethyl [3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoxy]-2-hydroxypropyl] hydrogen phosphate
2-Amino-3-[(3-heptadecanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
(2S)-2-amino-3-[hydroxy-[(2R)-1,1,2,3,3-pentadeuterio-3-heptadecanoyloxy-2-hydroxypropoxy]phosphoryl]oxypropanoic acid
(2S)-2-amino-3-[hydroxy-[(2R)-1,1,3,3-tetradeuterio-3-heptadecanoyloxy-2-hydroxypropoxy]phosphoryl]oxypropanoic acid
2-Amino-3-[2,3-di(octanoyloxy)propoxy-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-heptanoyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(3-butanoyloxy-2-dodecanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[(2-decanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(3-propanoyloxy-2-tridecanoyloxypropoxy)phosphoryl]oxypropanoic acid
2-Amino-3-[hydroxy-(3-pentanoyloxy-2-undecanoyloxypropoxy)phosphoryl]oxypropanoic acid
3-[(3-Acetyloxy-2-tetradecanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid
1,2-dioctanoyl-sn-glycero-3-phosphoserine
A 3-sn-phosphatidyl-L-serine in which the two phosphatidyl acyl groups are specified as octanoyl.
1-(2-methoxy-6Z-hexadecenyl)-sn-glycero-3-phosphoserine
1-(2-methoxy-5Z-hexadecenyl)-sn-glycero-3-phosphoserine
Sulfoglycolithocholate(2-)
A steroid sulfate oxoanion and N-acylglycinate that is the dianion of sulfoglycolithocholic acid arising from deprotonation of carboxylic acid and sulfate functions; major species at pH 7.3.
Upidosin
Upidosin (Rec 15/2739) is an α-1 adrenoceptor (α-1 AR) antagonist. Upidosin shows moderate selectivity for the α-1A AR subtype. Upidosin shows uroselectivity in urethra and prostate with a Kb value of 2-3 nM higher than in ear artery and aorta with a Kb value of 20-100 nM. Upidosin inhibits [3H]prazosin binding to cloned human α-1A adrenergic receptor. Upidosin can be used for the research of urethral obstruction[1].
3,9-dihydroxy-5-(1h-indol-3-ylmethyl)-7,8,14,16-tetramethyl-4,21-diazatetracyclo[16.2.1.0²,⁶.0²,¹⁰]henicosa-1(20),3,7,11,18-pentaen-17-one
(3s,3ar,4s,5r,6s,6ar,10s,12r,15r,15ar)-3-benzyl-1,5,6,12-tetrahydroxy-4,5,10,12-tetramethyl-3h,3ah,4h,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindol-15-yl acetate
(2e,6e)-7-[(1as,2r,2ar,5s,5ar,6s,6ar)-3-hydroxy-5-(1h-indol-3-ylmethyl)-6,6a-dimethyl-2a-(1h-pyrrol-2-yl)-1ah,2h,5h,5ah,6h-oxireno[2,3-f]isoindol-2-yl]-2,4-dimethylhepta-2,6-dienal
n-[2-(4-{[(2s,3s)-3-[(3r)-3,4-bis(acetyloxy)-4-methylpentyl]-3-methyloxiran-2-yl]methoxy}phenyl)ethyl]benzenecarboximidic acid
(2r,5s,6r,9s,10r,14s,16r)-3,9-dihydroxy-5-(1h-indol-3-ylmethyl)-7,8,14,16-tetramethyl-4,21-diazatetracyclo[16.2.1.0²,⁶.0²,¹⁰]henicosa-1(20),3,7,11,18-pentaen-17-one
(1s,5r,8r,9r,10r,11s,12r,13s,15s,16r)-12-hydroxy-12-(hydroxymethyl)-5,7-dimethyl-7-azahexacyclo[7.6.2.2¹⁰,¹³.0¹,⁸.0⁵,¹⁶.0¹⁰,¹⁵]nonadecan-11-yl 3,4-dimethoxybenzoate
15-veratroyldictizine
{"Ingredient_id": "HBIN001729","Ingredient_name": "15-veratroyldictizine","Alias": "NA","Ingredient_formula": "C30H41NO6","Ingredient_Smile": "CC12CCCC34C1CC(C3N(C2)C)C56C4CC(CC5)C(C6OC(=O)C7=CC(=C(C=C7)OC)OC)(CO)O","Ingredient_weight": "511.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "22377","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21579303","DrugBank_id": "NA"}